English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
12 results
Freeze-dried lecithin nanometer powder injection of ursolic acid and its preparation method
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE PRESENT INVENTION
1. Field of Invention
The present invention relates to ursolic acid medicine, and more particularly, relates to freeze-dried ursolic acid nano-powder for injection as the preparation method thereof.
2. Description of Related Arts
Ursolic acid is a kind of organic
Methods and systems for treating or preventing cancer
Only registered users can translate articles
Log In/Sign up
FIELD
The present invention generally relates to compositions and methods for transdermal delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Methods and systems for treating or preventing cancer
Only registered users can translate articles
Log In/Sign up
FIELD
The present invention generally relates to compositions and methods for transdermal delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Methods and systems for treating or preventing cancer
Only registered users can translate articles
Log In/Sign up
FIELD
The present invention generally relates to compositions and methods for transdermal delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Methods and systems for treating or preventing cancer
Only registered users can translate articles
Log In/Sign up
FIELD
The present invention generally relates to compositions and methods for transdermal delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Cancer treatments and compositions for use thereof
Only registered users can translate articles
Log In/Sign up
FIELD
The present invention generally relates to compositions and methods for transdermal drug delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Cancer treatments and compositions for use thereof
Only registered users can translate articles
Log In/Sign up
FIELD
The present invention generally relates to compositions and methods for transdermal drug delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Cancer treatments and compositions for use thereof
Only registered users can translate articles
Log In/Sign up
FIELD
The present invention generally relates to compositions and methods for transdermal drug delivery, including treatment of cancer and other conditions.
BACKGROUND
Cancer is a group of diseases that involves unregulated cell growth. Cancer is usually treated with chemotherapy, radiation therapy,
Sustained peptide-release formulation
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention relates to formulations for the sustained release of peptide agonists and analogues. In a particular application of the invention, the formulation comprises a peptide agonist or analogue of gonadotropin releasing hormone (GnRH) and is used for the
Sustained GnRH peptide-release formulation
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention relates to formulations for the sustained release of peptide agonists and analogues. In a particular application of the invention, the formulation comprises a peptide agonist or analogue of gonadotropin releasing hormone (GnRH) and is used for the
Sustained peptide-release formulation
Only registered users can translate articles
Log In/Sign up
FIELD OF THE INVENTION
The present invention relates to formulations for the sustained release of peptide agonists and analogues. In a particular application of the invention, the formulation comprises a peptide agonist or analogue of gonadotropin releasing hormone (GnRH) and is used for the
Oral formulations of kinase inhibitors
Only registered users can translate articles
Log In/Sign up
BACKGROUND
Small-molecule inhibitors of various classes of kinases have become significant exploratory medicinal compounds. However, certain kinase inhibitors possess properties of low water solubility and poor oral bioavailability.
Among the various classes of kinases for which experimental
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
